| A Study of Long-Term Safety and Efficacy of Lanadelumab for Prevention of Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor (NCT04444895) | Shire | 2021-02-05 |
| Mepolizumab in Episodic Angioedema With Eosinophilia (NCT04128371) | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-01-14 |
| Lanadelumab in Bradykinin Angioedema (NCT04597944) | University Hospital, Grenoble | 2020-09-18 |
| A Study of Lanadelumab in Teenagers and Adults to Prevent Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH) (NCT04206605) | Takeda | 2020-05-04 |
| CLOUD-R HAE REGISTRY (NCT03845946) | University Hospital, Grenoble | 2018-09-01 |
| Study of Clinical, Biological Characteristics and Quality of Life of Patients With Hereditary or Acquired Non Drug-induced Bradykinin-mediated Angioedema, Monitored in Besançon's Partner Site Reference Center for Studies of Kinin-mediated Angioedema (CREAK) (NCT03240991) | Centre Hospitalier Universitaire de Besancon | 2016-07-11 |
| Impact of Omalizumab on Quality of Life Measures and Angioedema Occurrence in Patients With CSU Refractory to Therapy (NCT01723072) | Novartis Pharmaceuticals | 2013-01-23 |
| Determination of Specific Biomarkers of Angioneurotic Crisis (NCT02833675) | University Hospital, Grenoble | 2012-10-01 |
| The Role of Vitamin D in Chronic Urticaria and Angioedema Treatment (NCT01371877) | University of Nebraska | 2011-11-01 |
| Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema (NCT01036659) | Bernstein, Jonathan A., M.D. | 2010-05-01 |
| Vitamin D Levels in Subjects With Chronic Urticaria and Angioedema (NCT00876369) | University of Nebraska | 2009-09-01 |
| A Randomized, Double-Blind, Placebo-Controlled Study of Omalizumab for Idiopathic Anaphylaxis (NCT00890162) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-04-27 |
| C1-Esteraseremmer-N for the Treatment of Hereditary (and Acquired) Angioedema (NCT00125541) | Prothya Biosolutions | 2006-11-01 |
| C1-Esteraseremmer-N for the Treatment of Hereditary (and Acquired) Angioedema (NCT00125151) | Prothya Biosolutions | 2006-02-01 |
| The Efficacy of a Pseudoallergen-Free Diet in the Treatment of Chronic Idiopathic Urticaria and/or Angioedema (NCT00163839) | Bayside Health | 2005-09-01 |
| Significance of an Elimination and Provocation Diet in Patients With Chronic Urticaria (NCT00385372) | University Hospital Muenster | 2005-01-01 |
| Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema (NCT00097695) | Shire | 2004-12-28 |
| Study of Heparin Prophylaxis of Hereditary Angioedema Exacerbations (NCT00004694) | University of Iowa | 1994-01-01 |
| AMelioration of Angiotensin Converting Enzyme Inhibitor Induced Angioedema Study (NCT01154361) | Technical University of Munich | |
| Expanded Access for the Prevention of Acute Attacks of 1) Hereditary Angioedema (HAE) in Children and 2) Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH) in Teenagers and Adults (NCT04583007) | Shire | |